RxDoctor Payments Data

Gregory Galano, MD

Orthopaedic Surgery · New York, NYNPI 1467611863

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $80,438 of the $114,588 with a category attached, or 70.2%. Stryker accounts for 88.0% of it on its own, with 16 other manufacturers making up the rest. Among orthopaedic surgery clinicians in NY with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$114,588in general payments, 2019–2025

Across 241 payments — averaging $475.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stryker$101K
  • Gotham Surgical Solutions & Devices, Inc.$3K
  • Smith+Nephew$3K
  • Arthrex$2K
  • Johnson & Johnson$1K
  • Zimmer Biomet$955
  • plus $3K from 11 others

What the payments were for

  • Consulting fees$80,43870%
  • Travel & lodging$14,71113%
  • Food & beverage$15,77814%
  • Education$3,6613%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$114,588 in reported general payments places this provider in the 90th percentile of 1,079 orthopaedic surgery providers in New York.

See all orthopaedic surgery providers in New York →

Medicare billing

Part B allowed, 2024
$116,989
Medicare patients
157
Services billed
3,749

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Diclofenac Sodium21$412
Meloxicam45$190
Ibuprofen12$78

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in New York

See the full list for New York →

Where these figures come from

Is this you, or does something look wrong? →